Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Active:	Yes
Cancer Type:	Neuroblastoma Neurologocal Tumor	NCT ID:	NCT02559778
Trial Phases:	Phase II	Protocol IDs:	NMTRC012 (primary) NCI-2015-01822
Eligibility:	0 - 22 Years, Male and Female	Study Type:	Treatment
Study Sponsor:	Giselle Sholler
NCI Full Details:	http://clinicaltrials.gov/show/NCT02559778

Summary

A prospective open label, multicenter study to evaluate the feasibility and acute
toxicity of using molecularly guided therapy in combination with standard therapy
followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO
followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.

Treatment Sites in Georgia

Georgia Cancer Center at Augusta University
1411 Laney Walker Boulevard
Augusta, GA 30912
www.augusta.edu/cancer/

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.